Although further study will be needed to resolve the relationship between circulating tumor cells and cytotoxicity of CTLs, treatment with anti‐PD‐1/anti‐PD‐L1 mAb could be a promising strategy for metastatic ESCC. Here, CD274 is linked to esophageal squamous cell carcinoma.